EyePoint (EYPT) Common Equity (2011 - 2026)
EyePoint (EYPT) reported Common Equity of $230.5 million for Q1 2026, down 22.76% on a YoY basis from $298.4 million in Q1 2025, and down 24.71% sequentially from $306.1 million in Q4 2025.
EyePoint (EYPT) Common Equity (2011 - 2026) Analysis & Trends
EyePoint (EYPT) has 16 years of Common Equity data on file, last reported at $230.5 million in Q1 2026.
- For the quarter ending Q1 2026, Common Equity fell 22.76% year-over-year to $230.5 million; the trailing twelve-month figure through Mar 2026 stood at $230.5 million (down 22.76% YoY), and the FY2025 full-year result was $306.1 million, down 9.03% from the prior year.
- Common Equity declined to $230.5 million in Q1 2026, from $306.1 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $336.5 million in Q4 2024 to a low of $57.3 million in Q2 2023.
- A 5-year average of $195.7 million and a median of $218.7 million in 2024 frame the typical range for Common Equity.
- Across the five-year window, Common Equity slumped 62.17% in 2023 and surged 298.7% in 2024, its largest moves.
- Tracing EYPT's Common Equity over 5 years: stood at $96.4 million in 2022, then soared by 176.36% to $266.3 million in 2023, then gained by 26.35% to $336.5 million in 2024, then fell by 9.03% to $306.1 million in 2025, then dropped by 24.71% to $230.5 million in 2026.
- Business Quant data shows EYPT's Common Equity at $230.5 million in Q1 2026, $306.1 million in Q4 2025, and $200.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 251.12 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -98.34 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.76 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.36 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 19.36 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 31.42 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.79 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.50 Bn |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 | 230.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 230.47 Mn |
| Dec 31, 2025 | 306.11 Mn |
| Sep 30, 2025 | 200.18 Mn |
| Jun 30, 2025 | 246.01 Mn |
| Mar 31, 2025 | 298.40 Mn |
| Dec 31, 2024 | 336.50 Mn |
| Sep 30, 2024 | 218.73 Mn |
| Jun 30, 2024 | 228.31 Mn |
| Mar 31, 2024 | 249.93 Mn |
| Dec 31, 2023 | 266.32 Mn |
| Sep 30, 2023 | 58.62 Mn |
| Jun 30, 2023 | 57.26 Mn |
| Mar 31, 2023 | 78.39 Mn |
| Dec 31, 2022 | 96.37 Mn |
| Sep 30, 2022 | 136.35 Mn |
| Jun 30, 2022 | 151.37 Mn |
| Mar 31, 2022 | 166.82 Mn |
| Dec 31, 2021 | 184.38 Mn |
| Sep 30, 2021 | 92.75 Mn |
| Jun 30, 2021 | 106.87 Mn |